Navigation

Home
Team
Companies
News & Ideas
Careers
Investor Portal
Contact Us

Address

Bold Capital Partners
225 Santa Monica Blvd.
Suite 900
Santa Monica
CA 90401

Google Maps

Contacts

Email us

Socials

LinkedIn Twitter

Recent Investments

Figure AI

Omeat

Immunis Biomedical

Immunis Biomedical

Immunis Biomedical

Docbot

- Docbot - Docbot -

Docbot (acquired by Satisfai AI) is applying AI and computer vision to increase the accuracy and efficiency of gastroenterology diagnostics and procedures.

Visit Company Website

Andrew Ritter CEO

Technologies

Applied AI,

Computational Biology,

Exited

Follow

Company News

View All News

Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials

Gastrointestinal AI developer Docbot nets new CEO, series A funding for clinical trials

Gastrointestinal AI developer Docbot nets new CEO, series A funding for clinical trials

Docbot Closes Series A Financing Led by Khosla Ventures and Appoints Andrew J. Ritter as CEO

Docbot Closes Series A Financing Led by Khosla Ventures and Appoints Andrew J. Ritter as CEO

Docbot Announces Results of Study Evaluating Deep Learning Platform for Ulcerative Colitis Published in Journal, Gastroenterology

Docbot Announces Results of Study Evaluating Deep Learning Platform for Ulcerative Colitis Published in Journal, Gastroenterology

Thiel Foundation Announces 2019 Thiel Fellows

Thiel Foundation Announces 2019 Thiel Fellows

Jobs

Interested in a job at Docbot?

Next